Guardant Health, Inc.
A precision oncology company providing blood-based diagnostics for cancer care.
GH | US
Overview
Corporate Details
- ISIN(s):
- US40131M1099
- LEI:
- Country:
- United States of America
- Address:
- 3100 HANOVER STREET, 94304 PALO ALTO
- Website:
- https://guardanthealth.com/
- Industry:
- Other human health activities
Description
Guardant Health is a precision oncology company focused on transforming cancer care through its proprietary blood-based diagnostics. The company specializes in liquid biopsy technology, providing comprehensive genomic profiling (CGP) for patients with solid tumors. Its tests analyze circulating tumor DNA (ctDNA) from a simple blood draw to identify genomic alterations that can guide personalized treatment decisions. Guardant Health's portfolio addresses the full continuum of cancer care, including therapy selection for advanced cancer, recurrence monitoring, and early-stage cancer detection. By leveraging data and non-invasive technology, the company aims to improve clinical outcomes for patients at all stages of the disease.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Guardant Health, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Guardant Health, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Guardant Health, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
